HOMOLOGY MEDICINES INC's ticker is FIXX and the CUSIP is 438083107. A total of 53 filers reported holding HOMOLOGY MEDICINES INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $150,000 | -23.5% | 49,206 | -8.8% | 0.00% | – |
| Q4 2021 | $196,000 | -54.3% | 53,936 | -0.9% | 0.00% | -100.0% |
| Q3 2021 | $429,000 | +1.9% | 54,452 | -5.9% | 0.00% | 0.0% |
| Q2 2021 | $421,000 | -12.8% | 57,850 | +12.7% | 0.00% | 0.0% |
| Q1 2021 | $483,000 | -16.7% | 51,348 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $580,000 | +5.6% | 51,348 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $549,000 | -29.4% | 51,348 | +0.2% | 0.00% | 0.0% |
| Q2 2020 | $778,000 | +33.7% | 51,247 | +36.9% | 0.00% | 0.0% |
| Q1 2020 | $582,000 | -27.2% | 37,446 | -3.1% | 0.00% | 0.0% |
| Q4 2019 | $800,000 | +14.4% | 38,634 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $699,000 | -4.6% | 38,634 | +3.2% | 0.00% | 0.0% |
| Q2 2019 | $733,000 | +0.5% | 37,433 | +42.3% | 0.00% | 0.0% |
| Q1 2019 | $729,000 | +21.3% | 26,302 | -2.2% | 0.00% | 0.0% |
| Q4 2018 | $601,000 | +64.7% | 26,887 | +68.2% | 0.00% | 0.0% |
| Q3 2018 | $365,000 | +12.0% | 15,987 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $326,000 | – | 15,987 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 4,535,919 | $16,511,000 | 3.10% |
| Vida Ventures Advisors, LLC | 770,845 | $2,806,000 | 1.05% |
| Vivo Capital, LLC | 853,143 | $3,105,000 | 0.19% |
| AAF Wealth Management, LLC | 47,501 | $173,000 | 0.12% |
| OUP Management Co., LLC | 64,000 | $233,000 | 0.10% |
| GSA CAPITAL PARTNERS LLP | 195,596 | $712,000 | 0.09% |
| Temasek Holdings (Private) Ltd | 5,650,996 | $20,570,000 | 0.07% |
| Bellevue Group AG | 1,737,122 | $6,323,000 | 0.06% |
| XTX Topco Ltd | 26,212 | $95,000 | 0.05% |
| Virtus ETF Advisers LLC | 37,588 | $137,000 | 0.05% |